News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Illumina, Inc. (ILMN) Accuses Life Technologies (LIFE) of Infringing Patent



12/29/2011 6:36:37 AM

Illumina Inc. (ILMN), whose genetic analysis tools are used in disease research and drug development, accused Life Technologies Corp. (LIFE) of infringing one of its patents. Life Technologies’ Ion Personal Genome Machine and Ion OneTouch System infringe Illumina’s patent for a method of “making and decoding of array sensors with microspheres,” Illumina said in a complaint filed yesterday in federal court in San Diego. The company seeks a court order stopping the alleged infringement and unspecified damages. “Defendants’ infringing acts are willful in that they have knowledge of Illumina’s rights under the ‘431 Patent, but have continued to infringe, and actively induce and contribute to infringement by others,” lawyers for San Diego-based Illumina said in the complaint.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES